Cytomegalovirus Reactivation in Cancer Patients Receiving Chemotherapy
1 other identifier
observational
20
1 country
1
Brief Summary
Cytomegalovirus (CMV) infects most of the world population. This study is to understand if chemotherapy will increase the chance of reactivating CMV. The results may help us in determining when treatment is needed and perhaps Why is it needed.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Jun 2005
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2005
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2006
CompletedFirst Submitted
Initial submission to the registry
August 18, 2006
CompletedFirst Posted
Study publicly available on registry
August 21, 2006
CompletedAugust 21, 2006
January 1, 2006
August 18, 2006
August 18, 2006
Conditions
Keywords
Eligibility Criteria
You may qualify if:
- clinical diagnosis of any cancer
- chemotherapy is needed for more than 6 months
- age\>20 years old
You may not qualify if:
- those who do not agree to participate
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Mackay Memorial Hospital
Taipei, 10449, Taiwan
Related Links
MeSH Terms
Conditions
Study Officials
- PRINCIPAL INVESTIGATOR
Yen-Ta Lu, MD, PhD.
Mackay Memorial Hospital
Study Design
- Study Type
- observational
- Observational Model
- DEFINED POPULATION
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
August 18, 2006
First Posted
August 21, 2006
Study Start
June 1, 2005
Study Completion
January 1, 2006
Last Updated
August 21, 2006
Record last verified: 2006-01